Fatal splenic rupture after discontinuing treatment by ibrutinib and venetoclax in relapse/refractory mantle cell lymphoma

Autor:	L. Roulin, F. Lemonnier, Corinne Haioun
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Hematology Venetoclax business.industry General Medicine chemistry.chemical_compound chemistry Ibrutinib Internal medicine Refractory Mantle Cell Lymphoma medicine business
Zdroj:	Annals of Hematology. 100:1345-1347
ISSN:	1432-0584 0939-5555
DOI:	10.1007/s00277-021-04469-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::11fafeca1c834c2c91955b59823e1f52 https://doi.org/10.1007/s00277-021-04469-0 Zobrazit plný text záznamu Full text from SpringerLink